ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,035.69
-1.57%
Dow Jones
37,815.92
-1.49%
US Dollar vs MXN
17.1276
-0.15%
Brent Oil
85.28
-0.72%
Bitcoin
56,642.63
-6.51%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Seagen Inc (SGEN)

  7. Seagen Inc (SGEN) Noticias

SGEN Seagen Inc

228.74
0.00 (0.00%)
Pre Mercado
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Seagen Inc SGEN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 228.74 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
228.74
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/1/202405:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
26/12/202305:12EDGAR2Form 15-12G - Securities registration termination [Section..
18/12/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202316:25EDGAR2Form SC 13D/A - General statement of acquisition of..
15/12/202317:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202317:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202316:00PRNUSPADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA®..
14/12/202307:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
14/12/202307:29EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
14/12/202307:00EDGAR2Form 8-K - Current report
14/12/202307:00EDGAR2Form 25-NSE - Notification filed by national security..
12/12/202307:32EDGAR2Form 8-K - Current report
12/12/202306:43DJNPfizer to Close $43 Billion Seagen Acquisition This Week
10/12/202318:30BWADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy..
06/12/202307:15BWTUKYSA® (tucatinib) in Combination with Antibody-Drug..
30/11/202317:04DJNAstellas, Seagen: Cancer Treatment Padcev Supplemental..
30/11/202316:00BWFDA Grants Priority Review for Supplemental Biologics..
13/11/202320:37EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
13/11/202319:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202318:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202317:37EDGAR2Form 144 - Report of proposed sale of securities
09/11/202315:12EDGAR2Form 144 - Report of proposed sale of securities
03/11/202311:00BWSeagen Highlights First Solid Tumor Data for an ADCETRIS®..
02/11/202312:00BWNew Data for ADCETRIS® (brentuximab vedotin) with..
01/11/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202307:09EDGAR2Form 8-K - Current report
01/11/202307:00BWSeagen Third Quarter 2023 Financial Results Reflect Strong..
22/10/202309:30PRNUSGroundbreaking EV-302 Trial Significantly Extends Overall..
20/10/202306:22IHMARKETNEWSFriday’s Wall Street Highlights: SolarEdge, Intuitive..
19/10/202310:14EDGAR2Form 8-K - Current report
16/10/202307:00BWSeagen to Highlight Overall Survival Data for PADCEV® and..
12/10/202307:00BWSeagen to Report Third Quarter 2023 Financial Results on..
22/9/202318:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202318:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202318:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202318:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202306:02DJNMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits..

Su Consulta Reciente

NASDAQ
SGEN
Seagen
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados